Mabion reactivates MabionCD20 through rare disease collaboration with Oddifact
MabionCD20 is a monoclonal antibody originally developed by Mabion as a biosimilar candidate to MabThera and Rituxan therapies
MabionCD20 is a monoclonal antibody originally developed by Mabion as a biosimilar candidate to MabThera and Rituxan therapies
Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings
This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
Discussions focused on digital health, non-communicable diseases, resilient supply chains, medical innovation, and healthcare workforce development
The association is intended to strengthen healthcare delivery standards, particularly in Oncology services, and enhance patient care outcomes
Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
The conclave brought together over 1,000 delegates from across India and internationally
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
Subscribe To Our Newsletter & Stay Updated